GlassScriptPhysician profile
Hortense M Ngoe
NPI 1063943611
$3,689.26
in general payments reported to CMS, 2019-2025
29 companies · $974 in 2025
The $974 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $520 · 2022: $1,087 · 2023: $545 · 2024: $563 · 2025: $974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,081.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $642.19 | 2023-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $413.30 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $389.06 | 2021-2024 | Senza |
| Collegium Pharmaceutical, INC. | $254.54 | 2021-2025 | Belbuca |
| Painteq LLC | $247.09 | 2022 | |
| Abbvie INC. | $240.36 | 2022-2025 | |
| Grt US Holding, INC. | $213.92 | 2021-2022 | |
| Lilly USA, LLC | $209.44 | 2021-2023 | Reyvow, Emgality |
| Pfizer INC. | $140.56 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $137.02 | 2021-2025 | Relistor |
| Allergan, INC. | $82.72 | 2021-2022 | |
| Mml US, INC. | $67.95 | 2023-2025 | Reactiv8 |
| Biohaven Pharmaceuticals, INC. | $67.44 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $63.33 | 2022 | |
| Medtronic, INC. | $53.36 | 2022-2024 | Intellis Adaptivestim |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $52.89 | 2025 | |
| Amgen INC. | $47.66 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $45.85 | 2021 | |
| Spinal Simplicity, LLC | $44.85 | 2023-2024 | Ha Minuteman G3-R |
| Axsome Therapeutics, INC. | $43.29 | 2025 | Symbravo |
| Abbott Laboratories | $42.47 | 2022-2025 | Proclaim |
| Vertos Medical, INC. | $41.68 | 2023-2024 | Mild Device Kit |
| Bioventus LLC | $31.62 | 2024-2025 | Xcell, Durolane |
| Biodelivery Sciences International, INC. | $27.58 | 2021 | |
| Globus Medical, INC. | $22.96 | 2025 | Senza |
| Almatica Pharma LLC | $19.18 | 2021 | |
| Merz Pharmaceuticals, LLC | $17.10 | 2021 | |
| Averitas Pharma INC. | $16.68 | 2025 | Qutenza |
| G Medical Diagnostic Services, INC. | $13.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hortense Ngoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.